Amprius二季度收入超预期并再次上调2026年指引，但本条为同一财报催化后续转述

SpaceX tumble amid AI spending concerns; Musk outlines $1 trillion revenue target
Introduction & Market Context
Amprius Technologies presented second-quarter 2026 financial results on August 5, 2026, showcasing accelerating revenue growth and margin expansion that prompted the company to raise its full-year outlook for the second consecutive quarter. The silicon-anode battery maker reported revenue of $34.0 million, up 126% year-over-year and 19% sequentially, while gross margin reached 27%, nearly triple the 9% posted a year earlier. Shares jumped 13% to $12.22 following the results, which beat analyst expectations on both revenue and profitability metrics.
The company’s presentation emphasized a capital-efficient manufacturing strategy that has enabled rapid capacity expansion without significant fixed-cost investments, positioning Amprius to capture growing demand across drone, satellite, robotics, and electric mobility markets. With over 2 GWh of contracted manufacturing capacity and a clear path to NDAA compliance by late 2027, the company is targeting $600 million in revenue by 2030 with gross margins exceeding 30%.
Quarterly Performance Highlights
As shown in the following chart of quarterly revenue and gross margin trajectory, Amprius has delivered six consecutive quarters of sequential growth, with revenue climbing from $15 million in Q2 2025 to $34 million in Q2 2026.
The company’s financial performance showed improvement across multiple metrics. Revenue of $34.0 million represented 2.3 times the year-ago level, driven primarily by the SiCore silicon-anode battery platform, which accounted for 98% of quarterly sales. First-half 2026 revenue totaled $62.6 million, up 137% from the same period last year.
Gross margin expansion proved equally impressive, reaching 27% in the second quarter compared to 20% in Q1 2026 and just 9% a year earlier. Management attributed the improvement to better operating leverage, a more favorable mix of European sales and higher-margin pouch cells, and the fading impact of one-time costs and tariffs.
The detailed financial breakdown reveals progress toward profitability across key metrics.
Net loss narrowed to $5.1 million, or $0.04 per diluted share, from $6.4 million a year earlier. Excluding a $1.9 million non-cash warrant adjustment, the adjusted net loss was $3.2 million, or $0.02 per share, representing a 50% improvement year-over-year. Adjusted EBITDA improved to negative $1.0 million with a 3% margin, compared to negative $2.1 million and a 14% margin in Q2 2025.
The company ended the quarter with $74.5 million in cash and no debt, bolstered by $16.8 million from warrant and option exercises. Working capital stood at $113.2 million, nearly double the $59.8 million reported a year ago. Capital expenditures totaled $1.8 million, primarily supporting electrode coating build-out in Fremont funded by the Defense Innovation Unit.
Strategic Growth Drivers
Amprius outlined a dual-track go-to-market strategy leveraging both pack integration partners and direct OEM relationships to drive efficient revenue growth. The company emphasized that this approach has created a self-reinforcing growth flywheel.
The pack partner channel, which now accounts for more than 30% of cell sales, enables Amprius to reach multiple platforms through single relationships with core integrators like Upgrade Energy and Titan. These partners handle battery pack assembly and qualification, allowing Amprius cells to reach end customers without requiring re-qualification for each new application. The streamlined path from sample to volume ramp accelerates revenue growth while minimizing sales team overhead.
Direct OEM relationships complement this strategy by establishing tight technical partnerships that solve specific customer needs. These design wins, which include custom pouch cell sizes and chemistries, create recurring revenue streams and drive further innovation in cell development. The combination has produced six consecutive quarters of multi-segment revenue growth, with management highlighting year-over-year revenue growth of 126%.
Commercial momentum includes a purchase order from Stark Future representing a greater than $100 million opportunity, a $24 million order from a major new European UAV customer, and a contract for the Redwire Stalker Block 30 platform. These wins validate the company’s performance advantages and demonstrate expanding market acceptance across defense and commercial applications.
Capacity Expansion Strategy
Amprius is pursuing a capital-efficient contract manufacturing model that has enabled the company to secure more than 2 GWh of worldwide production capacity without building its own large-scale factories. The strategy spans three geographic regions with distinct strategic purposes.
In South Korea, the Korea Battery Alliance has more than doubled manufacturing volume through partnerships with cell makers, materials suppliers, component manufacturers, and equipment providers. Partners including TM Top Material, JR Energy Solution, and Libest build SiCore cells to Amprius specifications, leveraging the world-class lithium-ion manufacturing base for scale and cost efficiency. The company delivered its first NDAA-compliant cells from South Korea in September 2025 and expanded alliance capacity beyond 2.0 GWh by December 2025.
In the United States, a Defense Innovation Unit-funded pilot line in Fremont is on track to be fully operational by year-end 2026, with 13 of 30 tools already landed as part of an $18 million project. The domestic manufacturing base supports programs requiring secure supply and domestic content, with cylindrical and pouch cell scale production targeted for late 2027. In January 2026, Amprius contracted with Nanotech Energy for additional U.S. manufacturing capacity.
The timeline shows progressive expansion from 1.8 GWh of capacity in May 2025 to more than 2.0 GWh today, with full NDAA production capability expected before year-end 2027. Management emphasized that China and Korea supply scale while the U.S. anchors defense-qualified, domestic-content supply, creating a globally distributed and compliant manufacturing network.
Technology Leadership and Product Roadmap
Amprius positioned its silicon-anode technology as delivering performance advantages that enable new applications impossible with conventional graphite-anode batteries. The company’s presentation included detailed performance comparisons demonstrating clear superiority across multiple metrics.
The data shows Amprius cells achieving 520 Wh/kg gravimetric energy density compared to 285 Wh/kg for graphite-anode cells, representing an approximately 2X improvement by weight. Volumetric energy density reaches 1,300 Wh/L versus 715 Wh/L for conventional cells. The company’s silicon-anode platform also enables charge times under six minutes compared to 30 minutes for graphite-anode alternatives, while maintaining comparable or superior cycle life of 200-1,400 cycles depending on cell tuning.
The tunable platform allows Amprius to optimize cells for specific duty cycles, with energy-tuned, power-tuned, and life-tuned variants addressing different application requirements. This flexibility has enabled the company to develop over 25 SKUs across multiple form factors, including cylindrical and pouch cells in various sizes.
Looking forward, the company’s cell roadmap projects continued energy density improvements through late 2027.
High-energy cells are expected to exceed 550 Wh/kg by the second half of 2027, with an ultra-high-energy variant approaching 600 Wh/kg. High-power cells should surpass 500 Wh/kg, while long-cycle-life cells are targeted above 400 Wh/kg. These improvements will further extend Amprius’s performance lead over conventional lithium-ion technology.
The roadmap aligns different cell types with specific applications: high-energy cells for drones, robots, and scooters where long uptime enables range and usability; high-power cells for aircraft and tools requiring sustained high-power bursts; and long-cycle-life cells for satellites, medical devices, and other applications demanding extended service life with high energy density.
Market Opportunities and Positioning
Amprius identified multiple fast-growing end markets where high energy density creates competitive advantages and enables new capabilities. The company provided detailed market sizing and segmentation to illustrate the opportunity.
The global lithium-ion cell market for Amprius’s target segments is projected to grow from $7 billion in 2026 to $35 billion by 2035, representing a 160% compound growth rate. Light electric vehicles currently represent the largest segment at $5 billion, expected to reach $10 billion by 2035 with a 9% annual growth rate. UAVs comprise a $2 billion market in 2026, growing to $5 billion by 2035 at 15% annually.
The highest-growth segments include robotics, expanding from near zero in 2026 to $11 billion by 2035 at a 58% compound annual growth rate, and eVTOL aircraft, projected to reach $1 billion by 2035 at 46% annually. Satellites and space applications represent an $8 billion opportunity by 2035, growing at 5% per year. These projections, based on a May 2026 study by Ratel Consulting, demonstrate the breadth of Amprius’s addressable market.
The drone market received particular attention given its near-term revenue significance. The presentation included detailed segmentation of surveillance drone platforms by class.
The analysis spans five categories from nano/micro ISR drones with 15-40 Wh batteries and $40-100 cell content per aircraft, to high-altitude pseudo-satellites requiring 5-15 kWh batteries with the highest dollar content per platform. Group 3 tactical UAS platforms, which include systems like the Insitu ScanEagle and AeroVironment JUMP 20, represent particularly attractive opportunities with 3-10 kWh battery requirements and $10,000-30,000 potential cell content per aircraft for missions lasting 8-16 hours.
The company also detailed attack and counter-attack drone segments, where platforms consume battery packs for every mission, creating recurring demand. These range from FPV strike drones with $150-400 cell content per consumed aircraft to medium loitering munitions with $3,000-8,000 cell content per round. The expendable nature of many military drone platforms creates a fundamentally different demand pattern than reusable commercial applications.
Financial Outlook and Long-Term Targets
Based on first-half performance and clearer second-half demand visibility, Amprius raised its full-year 2026 guidance for the second consecutive quarter.
The company now expects revenue of at least $140 million for 2026, up from at least $130 million projected in May and greater than $125 million initially forecast in March. Gross margin guidance increased to at least 28% from above 25% previously. The company reiterated its adjusted EBITDA target of greater than $4 million, representing approximately a 3% margin, and maintained net loss guidance of $10.0 million, or $8.0 million excluding the $1.9 million non-cash warrant fair value charge.
Capital expenditure is expected to remain below $10 million for the full year, with spending primarily supporting DIU-backed investments in Fremont while preserving the capital-efficient, low fixed-cost manufacturing model. Management emphasized that the raised guidance reflects stronger baseline performance and investment in long-term growth rather than pulling forward future revenue.
The company’s long-term targets extend the growth trajectory through 2030.
Amprius is targeting revenue exceeding $600 million by 2030 based on contracted gigawatt-hour capacity, with gross margins above 30% and adjusted EBITDA margins of at least 20%. This represents a nearly 8X increase from 2025 actual revenue of $73 million while expanding margins by approximately 1,900 basis points on a gross basis and 2,700 basis points on an adjusted EBITDA basis.
The progression from 2025 actuals through 2026 outlook to 2030 targets shows consistent improvement across all financial metrics. The company exited Q4 2025 at a 25% gross margin run rate and achieved positive 7% adjusted EBITDA in that quarter, demonstrating that profitability at scale is achievable with the current business model.
Geographically, the supply chain will continue expanding from the current base in the United States, South Korea, and China to include additional allied nations by 2030. This diversification supports both commercial scale requirements and defense-specific NDAA compliance mandates, enabling Amprius to serve the full spectrum of customer needs.
NDAA Compliance and Defense Market Access
A significant portion of the presentation addressed NDAA compliance requirements and their implications for the U.S. defense battery supply chain. Section 154 of the FY2024 NDAA bars the Department of Defense from purchasing batteries produced by six named Chinese manufacturers: CATL, BYD, Envision Energy, EVE Energy, Gotion, and Hithium. These firms collectively supply the majority of the world’s lithium-ion cells, creating a substantial supply gap for defense applications.
The regulations phase in progressively from 2027 through 2029. Section 805 direct-procurement bans took effect in June 2026, while Section 154 restrictions on the six Chinese battery makers become mandatory in October 2027. By 2027, cell materials and components must be sourced from NDAA-authorized countries, and by January 2028, battery cells themselves must be produced in the United States or allied nations. By January 2029, standard batteries must achieve 75% Buy American content.
Amprius’s strategy of establishing manufacturing partnerships in South Korea and the United States positions the company to meet these requirements ahead of the mandatory deadlines. The company delivered its first NDAA-compliant cells from South Korea in September 2025 and is on track for full domestic production capability by late 2027, well before the January 2028 requirement for U.S. or allied-nation cell production.
The defense market opportunity is substantial given the Pentagon’s increasing focus on autonomous systems, long-endurance ISR platforms, and counter-UAS capabilities. Chief Executive Tom Stepien noted that "our current contract with the Defense Innovation Unit gives us a front-row seat in this arena," referring to both the $18 million pilot line funding and Amprius’s broader positioning in defense-qualified battery supply.
Challenges and Risk Factors
Despite strong momentum, the presentation acknowledged several execution risks and operational challenges. While the company is approaching breakeven on a trailing twelve-month adjusted EBITDA basis, it remains unprofitable on a GAAP basis and depends on continued revenue growth and margin expansion to achieve sustained profitability.
Supply chain complexity remains elevated as Amprius coordinates with multiple contract manufacturers across three continents. The company must maintain quality control and specification compliance across this distributed network while managing relationships with materials suppliers, component manufacturers, and equipment providers. Any disruption in the contract manufacturing network could impact production capacity and delivery timelines.
NDAA compliance, while progressing on schedule, involves substantial legal, operational, and planning work. The company has qualified two sets of 11 suppliers for key battery components and expects to complete contracting this quarter, but the process requires ongoing validation and documentation. Meeting the January 2028 deadline for U.S. or allied-nation cell production remains a critical milestone.
Revenue concentration in a few markets, particularly drones and electric mobility, creates potential volatility in quarterly results. While the company is expanding into robotics, data centers, and other applications, these remain early-stage opportunities with no meaningful revenue contribution yet. Management acknowledged that visibility into 2027 becomes less clear, which could complicate long-term forecasting and capacity planning.
The competitive landscape continues evolving as other battery manufacturers pursue silicon-anode and advanced lithium-ion technologies. Maintaining technology leadership will require continued R&D investment and successful execution of the cell roadmap. The company’s ability to scale production while preserving performance advantages and cost competitiveness will determine its long-term market position.
Capital efficiency, while a core strategic advantage, also limits the company’s control over manufacturing operations and requires effective partner management. Any misalignment between Amprius’s specifications and partner execution could impact product quality or delivery schedules. The company must balance the benefits of asset-light operations against the risks of relying on third-party manufacturers for critical production.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.